Apretude
Data Shows Preference for CAB-LA PrEP Without Straining Clinics
Two studies presented at IAS 2025 demonstrated the acceptability and feasibility of using Apretude for PrEP in ...
JULY 22, 2025
Overcoming the Challenges of Adhering to Injectable ART and PrEP
Before 2021, oral medication was the only option for HIV prevention and treatment, but adherence has always been a ...
JUNE 27, 2024
Load more